denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinically relevant, Quality Improvement
Hematology Disease Topics & Pathways:
Clinically relevant, Quality Improvement
Sunday, December 6, 2020: 11:55 AM-12:00 PM
Chair:
Anita Rajasekhar, MD, MS, University of Florida - Shands Hospital
Disclosures:
Rajasekhar: Baxalta: Research Funding; Genentech: Research Funding; Janssen Pharmaceuticals: Research Funding; Sanofi-Genzyme: Research Funding; Biomarin Pharmaceuticals: Research Funding; Dimension Therapeutics: Research Funding; Kedrion: Other: advisory board; medical legal expert review: Consultancy.
In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.
The live Q&A for this session will take place <a href="ash20.stage.onlineeventapp.com/live-stream/19756588/ASH-Choosing-Wisely-Campaign-2020-ASH-Choosing-Wisely-Champions---Live-QA">here</a> on Sunday, December 6 at 12:00 noon.
See more of: Special-Interest Sessions